Aims: The aim of our study was to measure granulocyte and monocyte phagocytosis following treatment of cells with some metabolites of aliphatic alcohols alone and in combination with acetaldehyde. Methods: The cells were separated from human peripheral blood prior to determination of phagocytosis of opsonized zymosan particles by granulocytes and monocytes treated individually with metabolites of aliphatic alcohols including formaldehyde, 1-propanal, acetone, 1-butanal, and 2-butanone and in combination with acetaldehyde. Results: The findings revealed that metabolites of aliphatic alcohols inhibited phagocytosis by granulocytes and monocytes in a concentration-dependent manner and when combined with acetaldehyde, they caused a further decrease in phagocytic activity. Conclusion: Due to their additive effects, it is possible that, in combination with acetaldehyde, metabolites of aliphatic alcohols may inhibit phagocytosis at physiologically realistic concentrations in episodic heavy drinkers, thereby contributing to their increased susceptibility to infectious diseases.
INTRODUCTION
Discussion of the health effects of alcoholic beverages has, understandably, been dominated by the role of ethanol and, to a much lesser extent, its main metabolite, acetaldehyde (Guo and Ren, 2010) . This is logical as ethanol is the main constituent of alcoholic beverages; its metabolic pathways and effects on tissues are well understood (Zakhari, 2006) . It is unquestionably the main contributor to the very high global burden of disease attributable to alcohol consumption, accounting for an estimated 3.3 million deaths and 139 million disability adjusted life years worldwide in 2012 (World Health Organization, 2014) . There are, however, other substances, less well studied, that are present in alcoholic beverages that may be toxic, either through their direct effect or via metabolites (Rehm et al., 2014) .
Their presence in different products varies, according to the raw materials and the means of fermentation and distillation (Rehm et al., 2010 (Rehm et al., , 2014 . They can include methanol and aliphatic alcohols (AAs) comprising more than two carbon atoms, also called higher alcohols, such as 1-and 2-propanol, 1-, and 2-butanol (Szű cs et al., 2005) . Chemical analysis of a range of European alcoholic beverages has found average concentrations of AAs of 85 and 319 mg/l in beer and wine samples, respectively but in distilled spirits this figure can be as high as 1,836 mg/l (Gilg, 2012a) .
Although AAs in spirits are consumed in many other parts of the world, concern about exposure to these substances has been greatest in certain countries of Central and Eastern Europe (CEE) where their consumption may contribute to the high rates of premature mortality from chronic liver diseases and cirrhosis (Szű cs et al., 2005; Rehm et al., 2010 Rehm et al., , 2014 World Health Organization, 2014) . More recently, a further concern has emerged, suggesting that these substances could contribute to the immunosuppression, and thus susceptibility to infectious diseases seen in heavy drinkers, influencing lymphocyte, granulocyte and monocyte functions (Árnyas et al., 2012; Désy et al., 2012) . However, by analogy with ethanol, whose metabolite acetaldehyde is even more toxic than its precursor (World Health Organization, 1995; Zakhari, 2006; Guo and Ren, 2010) , it is important to ascertain whether the metabolites of these substances are potentially harmful. As with ethanol, other AAs are metabolized in the liver by alcohol dehydrogenase (ALD) enzymes, with methanol, 1-and 2-propanol, and 1-and 2-butanol giving rise to formaldehyde, 1-propanal, acetone, 1-butanal, and 2-butanone, respectively (World Health Organization, 1987 , 1989 , 1990a .
Although some effects of acetaldehyde and formaldehyde on tissues are already known, research on human immune cells has been limited (World Health Organization, 1989 , 1995 , 1998 ; Agency for Toxic Substances and Disease Registry, 1992) . However, Vrsalovic et al. (2007) reported that acetaldehyde can inhibit granulocyte and monocyte phagocytosis. Intuitively, it seems plausible that metabolites of AAs could also influence granulocyte and monocyte phagocytosis, but this has not previously been studied. Consequently, we have sought to investigate granulocyte and monocyte phagocytosis following treatment of cells with some metabolites of AAs alone and in combination with acetaldehyde, thereby providing evidence that not only higher alcohols found in spirits but also their corresponding metabolites may contribute to increased susceptibility to infectious diseases seen in heavy drinkers.
MATERIALS AND METHODS

Chemicals
Acetaldehyde, formaldehyde, acetone, 1-propanal, 1-butanal, and 2-butanone were purchased from Alfa Aesar (Karlsruhe, Germany). Ficoll-histopaque (1.077 and 1.119 g/ml), zymosan A particles (from Saccharomyces cerevisiae), fluorescein isothiocyanate (FITC), and 4′,6-diamidino-2-phenylindole (DAPI) were obtained from Sigma-Aldrich (Steinheim, Germany). Chamber slides for phagocytosis assay (8 wells/ slide) were acquired from VWR International LLC (Radnor, PA). Mouse anti-CD14 monoclonal antibody and anti-mouse IgG-conjugated Dylight 594 fluorescent dye were obtained from Beckton Dickinson Biosciences (Környe, Hungary) and Vector Laboratories (Peterborough, United Kingdom), respectively. Human AB serum was purchased from a local blood transfusion centre. All other chemicals were analytical grade.
Subjects
After informed consent and with the approval of the Institutional Ethical Committee at the University of Debrecen (number of ethical approval: DE OEC RKEB/IKEB 3649-2012), peripheral blood was collected into Vacutainer tubes containing EDTA (Becton-Dickinson, Cedex, France) from healthy volunteers (n = 15, 8 females and 7 males). These were staff of the Department of Preventive Medicine including lecturers, researchers, PhD students and office workers. The subjects were aged 22-46 years [mean = 32.13 ± 9.83 years]. All were non-smokers, not heavy drinkers, had normal dietary habits, and were not taking any alcohol/medications that could influence results of the experiments. Individual characteristics of the healthy volunteers are presented in Table 1 . Fasting blood samples were collected between 8 and 9 AM and processed immediately. Strenuous physical activity was not performed by the donors within 24 h before blood sampling. White blood cell counts of every donor were determined using a Buerker chamber. To yield adequate statistical power, each set of analyses was undertaken 20 times using blood from 15 subjects.
Separation of cells
Granulocytes and mononuclear cells were separated as described previously (English and Andersen, 1974) . In brief, blood samples were mixed with an equal volume of Hanks' balanced salt solution (HBSS, pH 7.4) and then layered on the top of a discontinuous Ficoll gradient (1.077 and 1.119 g/ml). The sample was then centrifuged at 400 g (20°C, 30 min). Granulocytes sedimented at the interface of Ficoll layers and mononuclear cells from the top of the separation medium were collected. The cells were washed twice with HBSS and their viability determined by trypan blue exclusion test (routinely 96-98%). The purity of granulocyte suspension varied between 95 and 98%, as judged by morphology. Granulocytes and mononuclear cells separated from different subjects were not combined into a single cell suspension. Each experiment was carried out with granulocytes and monocytes from individual donors.
Preparation of FITC-labelled and opsonized zymosan particles
Zymosan particles were labelled and opsonized as described previously (Hed et al., 1987) . Briefly, the particles (10 8 /ml) were incubated in carbonate buffer containing FITC at a final concentration of 0.01 mg/ml for 60 min at 37°C. The particles were then washed three times and opsonized for 30 min at 37°C in HBSS containing 50% human AB serum. The FITC-labelled opsonized particles (FITC-OZ) were then washed three times, resuspended in HBSS (at 3 × 10 7 /ml), and stored at −20°C until the phagocytosis assays.
Phagocytosis assay
Phagocytosis of the FITC-OZ was determined as described previously (Forslid and Hed, 1982; Szabo and Mandrekar, 2008) . Here, 10 6 /ml granulocytes and mononuclear cells in 300 µl aliquots (in HBSS containing 5% heat-inactivated human AB serum) were placed into the wells of chamber slides and the cells allowed to adhere for 30 min at room temperature. Non-adherent cells were removed by washing and the adherent cells and FITC-OZ (3 × 10 6 /well) were incubated in 300 µl aliquots of HBSS containing, separately acetaldehyde at concentrations of 0.005 mM, 0.05 mM, 0.5 mM, 5.0 mM, 10.0 mM and formaldehyde, acetone, 1-propanal, 1-butanal, 2-butanone at concentrations of 0.0005 mM, 0.001 mM, 0.005 mM, and 0.05 mM at 37°C in a 5% CO 2 /95% humidified air chamber for 60 min. To prevent evaporation, the stock solutions of aldehydes were prepared on ice, diluted with ice cold HBSS and aliquots of these solutions were added to each well of the chamber slides immediately before phagocytosis assay. The chamber slides were covered with a tight-fitting plastic lid to avoid evaporation of aldehydes from the incubation medium.
Other sets of granulocytes and monocytes were incubated in a mixture containing 0.10 mM acetaldehyde and each of the aliphatic alcohol metabolites at final concentrations of 0.0005 mM, 0.001 mM, 0.005 mM, or 0.05 mM. Untreated cells served as controls. The viability of phagocytic cells was checked using the trypan blue exclusion test after the treatments and was found to be 96-98%. Following incubation, the fluorescence of non-ingested particles was quenched by addition of 0.2% trypan blue solution and the cells were then fixed with a 4% paraformaldehyde solution. Monocytes were identified by an indirect immunofluorescent method. Firstly, the chamber slide cells were incubated at room temperature for 60 min in phosphate-buffered saline (PBS, pH 7.4) containing anti-CD14 monoclonal antibody (1:50 dilution). The cells were then rinsed three times with PBS. Monocytes incubated without anti-CD14 antibody served as negative controls. All monocytes were then stained with anti-mouse IgG conjugated with Dylight 594 fluorescent dye (1:200 dilution) for 45 min and finally they were washed four times with PBS. The nuclei of granulocytes and monocytes were stained with DAPI and the slide was then removed from the chamber for microscopic evaluation. The number of FITC-OZ/cell was determined with an Axioplan fluorescent microscope (Zeiss, Oberkochen, Germany) by examining 100 phagocytic cells in randomly selected microscopic fields/slide. Each treatment was evaluated in duplicate; each slide was assessed twice/sample. From these values, the phagocytosis index (PI, average number of ingested particles/cell) was calculated.
Statistical analysis
All results are presented as mean values [± SD] from six independent experiments. Differences in phagocytosis by untreated granulocytes and monocytes and cells treated with aliphatic alcohol metabolites were determined by one-way analysis of variance (ANOVA) using a Newman-Keuls post hoc test. Phagocytic activity of cells from female and male donors was compared using an unpaired t-test. P-values <0.05 were considered statistically significant.
RESULTS
There was no statistically significant difference in phagocytic activity between untreated granulocytes and monocytes from female and male donors (P > 0.05). As shown in Fig. 1A, both There was a significant difference between the phagocytic activity of untreated cells (Gr-PI: 5.12; Mo-PI: 4.69) and cells exposed to formaldehyde (Fig. 1B) Fig. 1F ] resulted in a concentration-dependent inhibition of phagocytosis. As shown in Fig. 2A and B, phagocytosis index was also significantly decreased when cells were exposed to a mixture containing each metabolite of AAs at final concentrations of 0.0005-0.05 mM [Gr-PI: 4.42; Mo-PI: 4.04 (control), 0.0005 mM (Gr-PI: 4.07; Mo-PI: 3.35), 0.001 mM (Gr-PI: 3.58; Mo-PI: 3.11), 0.005 mM (Gr-PI: 3.15; Mo-PI: 2.67), and 0.05 mM (Gr-PI: 2.42; Mo-PI: 2.09)]. Compared to the cells treated only with 0.1 mM acetaldehyde (Gr-PI: 2.61; Mo-PI: 2.42), granulocytes and monocytes incubated with a mixture containing 0.1 mM acetaldehyde and aliphatic alcohol metabolites [0.001 mM (Gr-PI: 2.45), 0.005 mM (Gr-PI: 2.22; Mo-PI: 1.97), 0.05 mM (Gr-PI: 1.82; Mo-PI: 1.34), Fig. 2A and B] showed significantly decreased phagocytosis.
DISCUSSION
Previous epidemiological studies have showed a strong relationship between heavy drinking and risk of severe bacterial and viral infections such as pneumonia, tuberculosis, Hepatitis B and C (Szabo, 1999; Molina et al., 2010) . The immune-modulatory effects of ethanol have been proposed as potential mechanism underlying increased susceptibility to pathogenic microorganisms in heavy drinkers (Goral et al., 2008; Molina et al., 2010) . However, recent in vitro and in vivo experiments have suggested that, besides ethanol, acetaldehyde, the main metabolite of ethanol, should be considered as a cause of immune system dysfunction in heavy drinkers (Tuma and Casey, 2003) . However, other aldehydes, such as formaldehyde, 1-propanal, acetone, 1-butanal, 2-butanone, can be formed by ADH in the liver following consumption of alcoholic beverages containing aliphatic alcohols (World Health Organization, 1987 , 1989 , 1990a . These aldehydes may induce immune-modulatory effects beyond that seen with acetaldehyde. Since 34% of the total recorded alcohol is consumed in the form of distilled spirits in Europe, it was reasonable to examine whether the ingestion of spirits containing AAs might pose an additional risk factor for development of ethanol-induced immunosuppression in heavy drinkers (World Health Organization, 2014) . However, it is important to note that although the concentration of AAs is highest in spirits, exposure to these substances may mainly be derived from beer and wine due to their greater contribution to overall consumption in some countries including Germany and France (World Health Organization, 2014) .
Our results demonstrated that metabolites of AAs could inhibit phagocytosis by human granulocytes and monocytes in a concentrationdependent manner and, when combined with acetaldehyde, could act additively. Having shown that AA metabolites act in this way, it is important to consider whether the concentration of these aldehydes in the blood of heavy drinkers after ingestion of spirits containing AAs could reach the levels tested in our study. Since acetaldehyde is the major metabolite during the biotransformation of ethanol, firstly we estimated its concentration in the blood of an episodic heavy drinker. Someone meeting the WHO criteria for an episodic heavy drinker would consume at least 60 g or more of pure alcohol on at least one occasion in a 7-day period (World Health Organization, 2014) . This would involve consumption of 190 ml of spirits containing 40% ethanol. Assuming this volume, the blood ethanol concentration would be 26.5 mM in man according to Widmark's equation (Brouwer, 2004) . Blood ethanol levels of 9.0-34.0 mM have been measured in healthy volunteers following alcohol intoxication and corresponding blood acetaldehyde concentrations were calculated to be 0.002-0.011 mM (reviewed in Eriksson, 2007) . The volume of spirits that would have The cells were separated from peripheral blood of healthy volunteers by Ficoll density gradient centrifugation. Subsequently, they were incubated in HBSS solution containing FITC-OZ and metabolites of aliphatic alcohols for 1 h at 37°C. Following treatment, phagocytic activities of control and treated cells were determined as described in the 'Materials and methods' section. Mean values (± SD) of six independent experiments are demonstrated. *P < 0.05, **P < 0.01, ***P < 0.001.
to be consumed to reach these acetaldehyde levels varies from 64.0-242.0 ml of spirits containing 40% ethanol (Brouwer, 2004) . Consequently, acetaldehyde concentrations in the blood of heavy drinkers could easily exceed the minimal level that inhibited the phagocytosis of granulocytes and monocytes (0.005 mM) in our study. However, heavy drinkers are likely to metabolize alcohols more quickly due to induction of ADH while, at the same time, they may have reduced liver aldehyde dehydrogenase (ALDH) activity, which can increase blood acetaldehyde concentration to 0.113-0.136 mM (5-6 mg/l) (Lieber, 1997; Zuba et al., 2002) . This level is higher than we used in mixture (0.10 mM) to examine the combined effects of aldehydes on the cells. Therefore, inhibition of phagocytosis in heavy drinkers could be more pronounced.
Due to their low concentration and high reactivity, determination of the other aliphatic aldehydes in body fluids is difficult and we have found only one report of the blood level of acetone in heavy drinkers after ingestion of beverage containing aliphatic alcohols (Zuba et al., 2002; Eriksson, 2007) . Therefore, it was necessary to estimate the concentration of aldehydes formed from AAs in spirits. Previous studies have shown that commercial spirits such as 'Kirschwasser' (German cherry spirit) contained, respectively, 37.2-79.7 mM methanol, 3.7-73.6 mM 1-propanol, 0.07-0.19 mM 1-butanol, 0.04-6.40 mM 2-butanol (Lachenmeier and Musshoff, 2004) . Assuming consumption of 64.0-242.0 ml of spirits containing 40% ethanol and AAs at the concentrations mentioned above, first we calculated the intake of each AA in millimole (mmol). Supposing equimolar biotransformation of AAs in the liver, the quantities of AAs and their corresponding aldehydes expressed in mmol were considered to be equal. As have been shown in toxicokinetic studies, during ethanol metabolism 95% of the acetaldehyde produced is further oxidized to acetate before leaving the liver (Eriksson, 1977; Eriksson and Sippel, 1977) . Therefore it is assumed that maximum 5% of remaining acetaldehyde could be released into the blood (Eriksson, 1977; Eriksson and Sippel, 1977) . Assuming that all aldehydes tested in our experiments follow the same metabolic pathway, and considering the volume of total body water of an average young adult man with body weight of 70 kg (42 l), we calculated the concentration of AA metabolites in body fluids (intracellular water, intersticial fluid, lymph water, blood plasma water) (Rodney and David, 2012) .
The levels of AA metabolites were assumed to be equal in each type of body fluid, including blood. The results obtained are presented in Table 2 . As demonstrated, consuming 64.0-242.0 ml of commercial Fig. 2 . Effects of acetaldehyde and mixture of aliphatic alcohol metabolites on phagocytosis by granulocytes (A) and monocytes (B). The cells were separated from peripheral blood of healthy volunteers by Ficoll density gradient centrifugation. Then, they were incubated in HBSS solution containing FITC-OZ and mixture of aliphatic alcohol metabolites or acetaldehyde and a mixture of aliphatic alcohol metabolites for 1 h at 37°C. Following treatment, phagocytosis of control and exposed cells was determined as described in the 'Materials and methods' section. Mean values (± SD) of six independent experiments are depicted. *P < 0.05, **P < 0.01, ***P < 0.001. The estimated concentrations of AAs metabolites in body fluids were calculated as described in the 'Discussion' section.
spirits (Kirschwasser) containing 40% ethanol and AAs could cause blood concentrations of formaldehyde 0.002-0.022 and 1-propanal 0.0002-0.021 mM, respectively (Table 2) . According to our calculations, drinking a moderate quantity (64.0 ml) of spirits would produce low concentrations of AA metabolites in the blood, so the effect of acetaldehyde is expected to predominate in this case. On the other hand when the volume of spirits consumed is 242.0 ml or higher, we estimate that the blood level of formaldehyde and 1-propanal, at least, could be as high as the minimal inhibitory concentrations observed in this study. The biological half-life of acetaldehyde in the blood of heavy drinkers was found to be 2.8 ± 1.1 hours (Zuba et al., 2002) . Assuming similar biological fates of formaldehyde and 1-propanal, the duration of phagocytosis inhibitory effects of these metabolites may be comparable to that of acetaldehyde or longer in persons consuming large volume of spirits habitually. In addition, previous studies have demonstrated that ALDH enzymes show higher specificity for acetaldehyde compared to aliphatic aldehydes containing more than two carbon atoms (Klyosov, 1996) . As a result, these aldehydes, especially acetone, may be enriched in the blood of heavy drinkers (Gilg, 2012b) . Consequently, their concentrations may be higher than our estimation based on the results of previous studies on toxicokinetics of acetaldehyde (Eriksson, 1977; Eriksson and Sippel, 1977) . Consequently, metabolites of AAs may be expected to inhibit phagocytosis by granulocytes and monocytes individually and in combination with acetaldehyde. However, further studies are required to answer this question definitively. While the exact mechanism by which these metabolites act is not known, previous studies have demonstrated that acetaldehyde can bind to tubulin molecules, the main components of cytoskeletal microtubules, thereby impairing the receptor mediated endocytosis by human hepatocytes (Tuma et al., 1991; Duryee et al., 2003) . It is also known that reorganization of microtubules plays an important role in mediating several cellular functions, such as chromosome movements, positioning cellular organelles, intracellular transport of membranous vesicles, and signal transduction (Harrison and Grinstein, 2002) . In addition, rearrangement of microtubules has been reported to be critical for mediating many granulocyte and monocyte functions including phagocytosis of pathogenic microorganism (Harrison and Grinstein, 2002) . During phagocytosis the rapid assembly of microtubules is required for engulfment of opsonized microorganisms and phagosome maturation (Damiani and Colombo, 2003; Khandani et al., 2007) . Supposedly, disturbances in microtubule reorganization may lead to decreased phagocytosis in granulocytes and monocytes. Therefore, we assume that, as with acetaldehyde, metabolites of AAs may bind to tubulin proteins of granulocytes and monocytes, thereby impairing the assembly of microtubules and inhibiting the phagocytic activity of these cells. However, further research is also needed to address this question.
In summary, our results indicate that AA metabolites can inhibit phagocytosis by human monocytes and granulocytes in a concentrationdependent manner. Clearly, the majority of adverse health effects of heavy drinking arise from the large volumes of ethanol that is consumed and its acetaldehyde metabolite. However, given the additive effects observed here, it is possible that, in combination with acetaldehyde, these substances may inhibit phagocytosis at physiologically relevant concentrations in heavy drinkers and episodic heavy drinkers, thereby contributing to their increased susceptibility to infectious diseases.
